Germany's Bayer to reprice and extend €3.5bn revolver
Bayer, the German chemicals and pharmaceuticals company, hopes to amend and extend a €3.5bn revolving credit facility from 2011, according to a senior loans banker.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
